{"id":"narcobarbital","rwe":[{"pmid":"9441044","year":"1997","title":"[Ban of the use of metomidate (Hypnodil) in swine. Background, consequences and alternatives].","finding":"","journal":"Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere","studyType":"Clinical Study"},{"pmid":"13957758","year":"1963","title":"[Debromination and narcobarbital in vitro].","finding":"","journal":"Ceskoslovenska farmacie","studyType":"Clinical Study"}],"tags":[{"label":"narcobarbital","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"N01AG01","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"enibomal","offLabel":[],"synonyms":["enibomal sodium","narcobarbital","enibomal"],"timeline":[],"approvals":[],"brandName":"Enibomal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"narcobarbital","explanation":"Imagine your brain is like a busy city with many different neighborhoods. Enibomal is like a traffic controller that helps regulate the flow of information between these neighborhoods. By doing so, it can help calm down overactive areas and restore balance to the brain.","oneSentence":"Enibomal is thought to work by modulating neural activity, but the exact mechanism is not well understood.","technicalDetail":"Enibomal is a small molecule that interacts with the GABA receptor, a key target for many anxiolytic and sedative agents. However, the precise binding site and mechanism of action are not well-characterized, and further research is needed to fully elucidate its pharmacology."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Narcobarbital","title":"Narcobarbital","extract":"Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States. It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3791","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=narcobarbital","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Narcobarbital","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T14:37:13.742307","biosimilars":[],"competitors":[],"genericName":"narcobarbital","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"M2BUZ8YH0F","CHEBI":"CHEBI:81294","UMLSCUI":"C0072155","ChEMBL_ID":"CHEMBL92963","DRUGBANK_ID":"DB13229","PUBCHEM_CID":"18735","SECONDARY_CAS_RN":"3329-16-6"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"N01AG01","allCodes":["N01AG01"]},"biosimilarFilings":[],"recentPublications":[{"date":"1997 Aug","pmid":"9441044","title":"[Ban of the use of metomidate (Hypnodil) in swine. Background, consequences and alternatives].","journal":"Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere"},{"date":"1963 Jan","pmid":"13957758","title":"[Debromination and narcobarbital in vitro].","journal":"Ceskoslovenska farmacie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Enibomal (narcobarbital) is a small molecule drug in the narcobarbital class, but information on its target, pharmacokinetics, and commercial status is limited. Its mechanism of action is not well-documented, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its safety and efficacy. Further research is needed to fully understand the properties and potential uses of Enibomal. Its current status is unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}